Cargando…
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a step towards curing HIV-1 infection. However, until now, approaches to reverse HIV-1 latency in humans have yielded mixed results. Here, we r...
Autores principales: | Søgaard, Ole S., Graversen, Mette E., Leth, Steffen, Olesen, Rikke, Brinkmann, Christel R., Nissen, Sara K., Kjaer, Anne Sofie, Schleimann, Mariane H., Denton, Paul W., Hey-Cunningham, William J., Koelsch, Kersten K., Pantaleo, Giuseppe, Krogsgaard, Kim, Sommerfelt, Maja, Fromentin, Remi, Chomont, Nicolas, Rasmussen, Thomas A., Østergaard, Lars, Tolstrup, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575032/ https://www.ncbi.nlm.nih.gov/pubmed/26379282 http://dx.doi.org/10.1371/journal.ppat.1005142 |
Ejemplares similares
-
Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals
por: Winckelmann, Anni, et al.
Publicado: (2018) -
Immune checkpoints and the HIV-1 reservoir: proceed with caution
por: Olesen, Rikke, et al.
Publicado: (2016) -
Fimepinostat, a novel dual inhibitor of HDAC and PI3K,
effectively reverses HIV-1 latency ex vivo without T cell activation
por: Gunst, Jesper D, et al.
Publicado: (2019) -
A5 Peripheral blood cells contribute to HIV-1 viremia induced by romidepsin
por: Winckelmann, A., et al.
Publicado: (2017) -
Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations
por: Winckelmann, Anni, et al.
Publicado: (2017)